25 XP   0   0   10

Guilin Sanjin Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Sanjin together

PenkeI guess you are interested in Guilin Sanjin Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guilin Sanjin Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guilin Sanjin Pharmaceutical Co Ltd

I send you an email if I find something interesting about Guilin Sanjin Pharmaceutical Co Ltd.

Quick analysis of Sanjin (30 sec.)










What can you expect buying and holding a share of Sanjin? (30 sec.)

How much money do you get?

How much money do you get?
¥0.54
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.79
Expected worth in 1 year
¥4.69
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥3.79
Return On Investment
24.9%

For what price can you sell your share?

Current Price per Share
¥15.25
Expected price per share
¥13.92 - ¥19.86
How sure are you?
50%

1. Valuation of Sanjin (5 min.)




Live pricePrice per Share (EOD)

¥15.25

Intrinsic Value Per Share

¥5.60 - ¥11.16

Total Value Per Share

¥10.39 - ¥15.95

2. Growth of Sanjin (5 min.)




Is Sanjin growing?

Current yearPrevious yearGrowGrow %
How rich?$388.8m$392.4m-$3.6m-0.9%

How much money is Sanjin making?

Current yearPrevious yearGrowGrow %
Making money$45.5m$47.5m-$1.9m-4.3%
Net Profit Margin16.8%19.7%--

How much money comes from the company's main activities?

3. Financial Health of Sanjin (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#143 / 1016

Most Revenue
#53 / 1016

Most Profit
#51 / 1016

Most Efficient
#88 / 1016

What can you expect buying and holding a share of Sanjin? (5 min.)

Welcome investor! Sanjin's management wants to use your money to grow the business. In return you get a share of Sanjin.

What can you expect buying and holding a share of Sanjin?

First you should know what it really means to hold a share of Sanjin. And how you can make/lose money.

Speculation

The Price per Share of Sanjin is ¥15.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sanjin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sanjin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.79. Based on the TTM, the Book Value Change Per Share is ¥-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.20 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.97 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sanjin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.080.5%0.080.5%0.080.5%0.080.5%0.090.6%
Usd Book Value Change Per Share0.000.0%0.000.0%-0.03-0.2%0.010.1%0.020.1%
Usd Dividend Per Share0.130.9%0.130.9%0.110.7%0.080.5%0.070.5%
Usd Total Gains Per Share0.130.9%0.130.9%0.080.5%0.080.6%0.090.6%
Usd Price Per Share1.83-1.83-2.34-1.96-2.25-
Price to Earnings Ratio23.57-23.57-29.04-24.48-25.24-
Price-to-Total Gains Ratio13.94-13.94-29.84-25.75-25.98-
Price to Book Ratio2.76-2.76-3.51-2.94-3.72-
Price-to-Total Gains Ratio13.94-13.94-29.84-25.75-25.98-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.10755
Number of shares474
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.130.08
Usd Book Value Change Per Share0.000.01
Usd Total Gains Per Share0.130.08
Gains per Quarter (474 shares)62.1039.85
Gains per Year (474 shares)248.42159.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1255-623814415149
2509-1248628831308
3764-1873443246467
41018-2598257661626
51273-31123072176785
61528-37147886592944
71782-43172610091071103
82037-49197411531221262
92291-55222212971371421
102546-62247014411531580

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%13.02.00.086.7%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.00.0100.0%

Fundamentals of Sanjin

About Guilin Sanjin Pharmaceutical Co Ltd

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, and sale of traditional Chinese and natural medicines in China. The company primarily offers Guilin watermelon frost and lozenge, and Sanjin tablets under the Chinese TCM brand; and Naomaitai capsules, etc. It also produces TCM preparations. Guilin Sanjin Pharmaceutical Co., Ltd. was founded in 1967 and is headquartered in Guilin, China. Guilin Sanjin Pharmaceutical Co., Ltd. operates as a subsidiary of Guilin SanJin Group Co.,Ltd.

Fundamental data was last updated by Penke on 2024-04-14 14:33:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Guilin Sanjin Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sanjin earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Sanjin to the Biotechnology industry mean.
  • A Net Profit Margin of 16.8% means that ¥0.17 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The MRQ is 16.8%. The company is making a huge profit. +2
  • The TTM is 16.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ16.8%TTM16.8%0.0%
TTM16.8%YOY19.7%-2.9%
TTM16.8%5Y20.8%-4.0%
5Y20.8%10Y24.5%-3.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.8%-197.2%+214.0%
TTM16.8%-210.4%+227.2%
YOY19.7%-279.3%+299.0%
5Y20.8%-436.8%+457.6%
10Y24.5%-599.3%+623.8%
1.1.2. Return on Assets

Shows how efficient Sanjin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sanjin to the Biotechnology industry mean.
  • 8.3% Return on Assets means that Sanjin generated ¥0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The MRQ is 8.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.3%TTM8.3%0.0%
TTM8.3%YOY8.4%-0.1%
TTM8.3%5Y9.5%-1.2%
5Y9.5%10Y12.1%-2.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3%-13.6%+21.9%
TTM8.3%-12.9%+21.2%
YOY8.4%-11.9%+20.3%
5Y9.5%-14.2%+23.7%
10Y12.1%-16.2%+28.3%
1.1.3. Return on Equity

Shows how efficient Sanjin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sanjin to the Biotechnology industry mean.
  • 11.7% Return on Equity means Sanjin generated ¥0.12 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The MRQ is 11.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.7%TTM11.7%0.0%
TTM11.7%YOY12.1%-0.4%
TTM11.7%5Y12.4%-0.7%
5Y12.4%10Y15.0%-2.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.7%-17.0%+28.7%
TTM11.7%-16.1%+27.8%
YOY12.1%-15.4%+27.5%
5Y12.4%-20.0%+32.4%
10Y15.0%-21.1%+36.1%

1.2. Operating Efficiency of Guilin Sanjin Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sanjin is operating .

  • Measures how much profit Sanjin makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sanjin to the Biotechnology industry mean.
  • An Operating Margin of 20.8% means the company generated ¥0.21  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The MRQ is 20.8%. The company is operating efficient. +1
  • The TTM is 20.8%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ20.8%TTM20.8%0.0%
TTM20.8%YOY18.3%+2.6%
TTM20.8%5Y23.5%-2.7%
5Y23.5%10Y21.5%+2.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.8%-286.1%+306.9%
TTM20.8%-224.4%+245.2%
YOY18.3%-288.4%+306.7%
5Y23.5%-475.2%+498.7%
10Y21.5%-624.7%+646.2%
1.2.2. Operating Ratio

Measures how efficient Sanjin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.08 means that the operating costs are ¥1.08 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The MRQ is 1.082. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.082. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.082TTM1.0820.000
TTM1.082YOY1.021+0.061
TTM1.0825Y1.024+0.058
5Y1.02410Y0.850+0.174
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0822.997-1.915
TTM1.0823.247-2.165
YOY1.0213.766-2.745
5Y1.0245.675-4.651
10Y0.8507.857-7.007

1.3. Liquidity of Guilin Sanjin Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sanjin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.71 means the company has ¥2.71 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The MRQ is 2.712. The company is able to pay all its short-term debts. +1
  • The TTM is 2.712. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.712TTM2.7120.000
TTM2.712YOY2.960-0.247
TTM2.7125Y3.800-1.088
5Y3.80010Y3.275+0.525
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7123.930-1.218
TTM2.7124.251-1.539
YOY2.9605.436-2.476
5Y3.8006.045-2.245
10Y3.2756.363-3.088
1.3.2. Quick Ratio

Measures if Sanjin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sanjin to the Biotechnology industry mean.
  • A Quick Ratio of 0.28 means the company can pay off ¥0.28 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The MRQ is 0.276. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.276. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.276TTM0.2760.000
TTM0.276YOY0.777-0.501
TTM0.2765Y0.905-0.629
5Y0.90510Y1.455-0.550
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2763.629-3.353
TTM0.2764.065-3.789
YOY0.7775.397-4.620
5Y0.9055.993-5.088
10Y1.4556.277-4.822

1.4. Solvency of Guilin Sanjin Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sanjin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sanjin to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.29 means that Sanjin assets are financed with 29.0% credit (debt) and the remaining percentage (100% - 29.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The MRQ is 0.290. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.290. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.290TTM0.2900.000
TTM0.290YOY0.307-0.016
TTM0.2905Y0.237+0.053
5Y0.23710Y0.202+0.036
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2900.332-0.042
TTM0.2900.334-0.044
YOY0.3070.268+0.039
5Y0.2370.366-0.129
10Y0.2020.390-0.188
1.4.2. Debt to Equity Ratio

Measures if Sanjin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sanjin to the Biotechnology industry mean.
  • A Debt to Equity ratio of 40.9% means that company has ¥0.41 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The MRQ is 0.409. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.409. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.409TTM0.4090.000
TTM0.409YOY0.442-0.033
TTM0.4095Y0.318+0.091
5Y0.31810Y0.259+0.059
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4090.381+0.028
TTM0.4090.390+0.019
YOY0.4420.334+0.108
5Y0.3180.434-0.116
10Y0.2590.466-0.207

2. Market Valuation of Guilin Sanjin Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Sanjin generates.

  • Above 15 is considered overpriced but always compare Sanjin to the Biotechnology industry mean.
  • A PE ratio of 23.57 means the investor is paying ¥23.57 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The EOD is 27.192. Based on the earnings, the company is overpriced. -1
  • The MRQ is 23.572. Based on the earnings, the company is fair priced.
  • The TTM is 23.572. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD27.192MRQ23.572+3.620
MRQ23.572TTM23.5720.000
TTM23.572YOY29.036-5.464
TTM23.5725Y24.480-0.907
5Y24.48010Y25.238-0.758
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD27.192-2.315+29.507
MRQ23.572-2.560+26.132
TTM23.572-2.664+26.236
YOY29.036-4.122+33.158
5Y24.480-6.258+30.738
10Y25.238-6.108+31.346
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The EOD is 19.212. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 16.654. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 16.654. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD19.212MRQ16.654+2.557
MRQ16.654TTM16.6540.000
TTM16.654YOY37.499-20.844
TTM16.6545Y24.982-8.328
5Y24.98210Y713.991-689.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD19.212-3.067+22.279
MRQ16.654-3.251+19.905
TTM16.654-3.545+20.199
YOY37.499-5.595+43.094
5Y24.982-8.315+33.297
10Y713.991-8.708+722.699
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sanjin is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.76 means the investor is paying ¥2.76 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Guilin Sanjin Pharmaceutical Co Ltd:

  • The EOD is 3.185. Based on the equity, the company is fair priced.
  • The MRQ is 2.761. Based on the equity, the company is underpriced. +1
  • The TTM is 2.761. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.185MRQ2.761+0.424
MRQ2.761TTM2.7610.000
TTM2.761YOY3.514-0.753
TTM2.7615Y2.938-0.177
5Y2.93810Y3.721-0.782
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.1851.905+1.280
MRQ2.7612.111+0.650
TTM2.7612.095+0.666
YOY3.5142.836+0.678
5Y2.9383.443-0.505
10Y3.7213.794-0.073
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guilin Sanjin Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.024-0.0240%-0.202+758%0.058-140%0.125-119%
Book Value Per Share--4.7884.7880%4.8120%4.828-1%4.452+8%
Current Ratio--2.7122.7120%2.960-8%3.800-29%3.275-17%
Debt To Asset Ratio--0.2900.2900%0.307-5%0.237+22%0.202+44%
Debt To Equity Ratio--0.4090.4090%0.442-7%0.318+29%0.259+58%
Dividend Per Share--0.9720.9720%0.769+26%0.550+77%0.533+82%
Eps--0.5610.5610%0.582-4%0.595-6%0.655-14%
Free Cash Flow Per Share--0.7940.7940%0.451+76%0.620+28%0.519+53%
Free Cash Flow To Equity Per Share---0.368-0.3680%-0.091-75%0.046-900%0.089-516%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--11.162--------
Intrinsic Value_10Y_min--5.601--------
Intrinsic Value_1Y_max--0.742--------
Intrinsic Value_1Y_min--0.535--------
Intrinsic Value_3Y_max--2.517--------
Intrinsic Value_3Y_min--1.640--------
Intrinsic Value_5Y_max--4.637--------
Intrinsic Value_5Y_min--2.771--------
Market Cap8960427616.000+13%7767662497.2807767662497.2800%9980282000.000-22%8369162099.456-7%9565687369.472-19%
Net Profit Margin--0.1680.1680%0.197-15%0.208-19%0.245-31%
Operating Margin--0.2080.2080%0.183+14%0.235-11%0.215-3%
Operating Ratio--1.0821.0820%1.021+6%1.024+6%0.850+27%
Pb Ratio3.185+13%2.7612.7610%3.514-21%2.938-6%3.721-26%
Pe Ratio27.192+13%23.57223.5720%29.036-19%24.480-4%25.238-7%
Price Per Share15.250+13%13.22013.2200%16.910-22%14.192-7%16.247-19%
Price To Free Cash Flow Ratio19.212+13%16.65416.6540%37.499-56%24.982-33%713.991-98%
Price To Total Gains Ratio16.085+13%13.94413.9440%29.835-53%25.746-46%25.977-46%
Quick Ratio--0.2760.2760%0.777-65%0.905-70%1.455-81%
Return On Assets--0.0830.0830%0.084-1%0.095-12%0.121-31%
Return On Equity--0.1170.1170%0.121-3%0.124-5%0.150-22%
Total Gains Per Share--0.9480.9480%0.567+67%0.608+56%0.658+44%
Usd Book Value--388802475.035388802475.0350%392462732.239-1%393434694.518-1%362408429.317+7%
Usd Book Value Change Per Share---0.003-0.0030%-0.028+758%0.008-140%0.017-119%
Usd Book Value Per Share--0.6620.6620%0.6650%0.667-1%0.615+8%
Usd Dividend Per Share--0.1340.1340%0.106+26%0.076+77%0.074+82%
Usd Eps--0.0780.0780%0.080-4%0.082-6%0.090-14%
Usd Free Cash Flow--64456709.21464456709.2140%36781970.761+75%50552920.494+28%42244276.979+53%
Usd Free Cash Flow Per Share--0.1100.1100%0.062+76%0.086+28%0.072+53%
Usd Free Cash Flow To Equity Per Share---0.051-0.0510%-0.013-75%0.006-900%0.012-516%
Usd Market Cap1238331096.531+13%1073490957.1241073490957.1240%1379274972.400-22%1156618202.145-7%1321977994.461-19%
Usd Price Per Share2.108+13%1.8271.8270%2.337-22%1.961-7%2.245-19%
Usd Profit--45540565.01345540565.0130%47501957.887-4%48529072.265-6%53282793.178-15%
Usd Revenue--270835079.303270835079.3030%240637233.176+13%234733784.466+15%220324778.885+23%
Usd Total Gains Per Share--0.1310.1310%0.078+67%0.084+56%0.091+44%
 EOD+4 -4MRQTTM+0 -0YOY+17 -185Y+12 -2310Y+15 -20

3.2. Fundamental Score

Let's check the fundamental score of Guilin Sanjin Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.192
Price to Book Ratio (EOD)Between0-13.185
Net Profit Margin (MRQ)Greater than00.168
Operating Margin (MRQ)Greater than00.208
Quick Ratio (MRQ)Greater than10.276
Current Ratio (MRQ)Greater than12.712
Debt to Asset Ratio (MRQ)Less than10.290
Debt to Equity Ratio (MRQ)Less than10.409
Return on Equity (MRQ)Greater than0.150.117
Return on Assets (MRQ)Greater than0.050.083
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Guilin Sanjin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.829
Ma 20Greater thanMa 5014.508
Ma 50Greater thanMa 10014.085
Ma 100Greater thanMa 20014.354
OpenGreater thanClose15.050
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,964,927
Total Liabilities1,151,595
Total Stockholder Equity2,813,332
 As reported
Total Liabilities 1,151,595
Total Stockholder Equity+ 2,813,332
Total Assets = 3,964,927

Assets

Total Assets3,964,927
Total Current Assets2,296,993
Long-term Assets1,667,933
Total Current Assets
Cash And Cash Equivalents 1,265,709
Short-term Investments 161,237
Net Receivables 72,167
Inventory 244,896
Other Current Assets 25,058
Total Current Assets  (as reported)2,296,993
Total Current Assets  (calculated)1,769,067
+/- 527,927
Long-term Assets
Property Plant Equipment 1,227,051
Goodwill 5,699
Intangible Assets 168,278
Other Assets 134,291
Long-term Assets  (as reported)1,667,933
Long-term Assets  (calculated)1,535,318
+/- 132,615

Liabilities & Shareholders' Equity

Total Current Liabilities846,936
Long-term Liabilities304,658
Total Stockholder Equity2,813,332
Total Current Liabilities
Short Long Term Debt 140,010
Accounts payable 133,917
Other Current Liabilities 409,809
Total Current Liabilities  (as reported)846,936
Total Current Liabilities  (calculated)683,736
+/- 163,200
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt78,452
Other Liabilities 98,177
Deferred Long Term Liability 125,762
Long-term Liabilities  (as reported)304,658
Long-term Liabilities  (calculated)302,391
+/- 2,268
Total Stockholder Equity
Common Stock587,569
Retained Earnings 1,572,869
Other Stockholders Equity 14,134
Total Stockholder Equity (as reported)2,813,332
Total Stockholder Equity (calculated)2,174,571
+/- 638,761
Other
Capital Stock587,569
Common Stock Shares Outstanding 587,569
Net Invested Capital 3,081,372
Net Tangible Assets 2,639,356
Net Working Capital 1,450,057
Property Plant and Equipment Gross 1,227,051



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-31
> Total Assets 
1,165,753
2,061,853
1,981,272
2,200,995
2,485,155
2,689,170
2,783,639
2,805,826
2,869,847
3,229,565
3,406,130
3,415,618
3,882,273
4,095,868
3,964,927
3,964,9274,095,8683,882,2733,415,6183,406,1303,229,5652,869,8472,805,8262,783,6392,689,1702,485,1552,200,9951,981,2722,061,8531,165,753
   > Total Current Assets 
0
0
0
0
0
0
0
1,546,244
1,576,367
1,950,140
2,126,658
1,987,080
2,379,897
2,454,133
2,296,993
2,296,9932,454,1332,379,8971,987,0802,126,6581,950,1401,576,3671,546,2440000000
       Cash And Cash Equivalents 
306,061
1,147,530
1,073,635
1,167,673
1,036,660
690,179
626,300
731,719
719,821
733,516
1,217,335
1,168,566
1,361,907
1,477,674
1,265,709
1,265,7091,477,6741,361,9071,168,5661,217,335733,516719,821731,719626,300690,1791,036,6601,167,6731,073,6351,147,530306,061
       Short-term Investments 
0
0
0
0
0
0
250,000
105,600
210,660
364,600
1
67,500
355,339
221,768
161,237
161,237221,768355,33967,5001364,600210,660105,600250,000000000
       Net Receivables 
426,345
477,979
350,432
294,377
462,350
544,531
598,937
497,689
483,328
635,045
639,878
529,506
44,898
422,134
72,167
72,167422,13444,898529,506639,878635,045483,328497,689598,937544,531462,350294,377350,432477,979426,345
       Other Current Assets 
28,258
57,552
19,768
66,904
117,156
321,290
16,250
18,292
8,499
17,480
25,414
27,049
62,100
48,402
25,058
25,05848,40262,10027,04925,41417,4808,49918,29216,250321,290117,15666,90419,76857,55228,258
   > Long-term Assets 
0
0
0
0
0
0
0
0
1,293,480
1,279,425
1,279,472
1,428,538
1,502,376
1,641,735
1,667,933
1,667,9331,641,7351,502,3761,428,5381,279,4721,279,4251,293,48000000000
       Property Plant Equipment 
334,949
298,966
428,765
537,098
719,594
917,632
932,535
1,029,758
1,036,748
1,028,243
1,052,461
1,223,399
1,300,263
1,313,278
1,227,051
1,227,0511,313,2781,300,2631,223,3991,052,4611,028,2431,036,7481,029,758932,535917,632719,594537,098428,765298,966334,949
       Goodwill 
0
0
0
0
0
0
7,221
7,221
7,221
5,699
5,699
5,699
5,699
5,699
5,699
5,6995,6995,6995,6995,6995,6997,2217,2217,221000000
       Long Term Investments 
0
0
0
0
0
0
0
15,396
50,596
53,879
28,096
0
0
0
0
000028,09653,87950,59615,3960000000
       Intangible Assets 
3,572
2,700
3,489
2,396
2,841
22,202
174,588
176,984
180,569
172,696
176,217
174,228
174,550
178,364
168,278
168,278178,364174,550174,228176,217172,696180,569176,984174,58822,2022,8412,3963,4892,7003,572
       Long-term Assets Other 
0
0
0
0
0
0
0
0
1,293,480
1,279,425
1,279,472
1,428,538
0
0
0
0001,428,5381,279,4721,279,4251,293,48000000000
> Total Liabilities 
378,649
278,999
181,472
218,177
407,265
486,112
463,069
419,731
444,257
575,653
599,467
600,181
923,271
1,256,051
1,151,595
1,151,5951,256,051923,271600,181599,467575,653444,257419,731463,069486,112407,265218,177181,472278,999378,649
   > Total Current Liabilities 
369,983
272,307
175,282
204,199
315,118
365,176
350,241
313,137
342,217
463,743
484,989
405,269
589,312
829,229
846,936
846,936829,229589,312405,269484,989463,743342,217313,137350,241365,176315,118204,199175,282272,307369,983
       Short-term Debt 
0
0
0
0
0
0
0
0
50,000
100,000
100,000
0
0
0
0
0000100,000100,00050,00000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
50,000
100,000
100,000
100,120
150,077
251,677
140,010
140,010251,677150,077100,120100,000100,00050,00000000000
       Accounts payable 
35,864
59,658
59,756
101,648
158,143
190,503
137,931
117,159
109,092
135,964
162,624
2,889
91,560
180,244
133,917
133,917180,24491,5602,889162,624135,964109,092117,159137,931190,503158,143101,64859,75659,65835,864
       Other Current Liabilities 
156,019
186,549
114,426
101,451
155,875
153,573
162,310
26,876
55,494
86,405
68,533
98,958
229,787
230,897
409,809
409,809230,897229,78798,95868,53386,40555,49426,876162,310153,573155,875101,451114,426186,549156,019
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
102,040
111,910
114,478
194,912
333,959
426,822
304,658
304,658426,822333,959194,912114,478111,910102,04000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
-50,000
-100,000
-100,000
0
102,527
87,933
78,452
78,45287,933102,5270-100,000-100,000-50,00000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
102,040
0
0
74,843
0
0
0
00074,84300102,04000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
16,132
15,199
11,808
11,149
16,197
16,792
128,799
125,762
125,762128,79916,79216,19711,14911,80815,19916,1320000000
> Total Stockholder Equity
778,263
1,773,496
1,791,819
1,982,818
2,077,890
2,203,058
2,320,570
2,386,095
2,425,590
2,653,912
2,806,663
2,815,437
2,959,002
2,839,817
2,813,332
2,813,3322,839,8172,959,0022,815,4372,806,6632,653,9122,425,5902,386,0952,320,5702,203,0582,077,8901,982,8181,791,8191,773,496778,263
   Common Stock
408,000
454,000
454,000
590,200
590,200
590,200
590,200
590,200
590,200
590,200
590,200
590,200
590,200
590,200
587,569
587,569590,200590,200590,200590,200590,200590,200590,200590,200590,200590,200590,200454,000454,000408,000
   Retained Earnings 
283,899
390,097
381,814
543,527
607,812
689,043
1,051,553
1,046,577
1,145,137
1,373,460
1,550,726
1,738,988
1,883,696
1,767,197
1,572,869
1,572,8691,767,1971,883,6961,738,9881,550,7261,373,4601,145,1371,046,5771,051,553689,043607,812543,527381,814390,097283,899
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
-1,143
-3,829
14,134
14,134-3,829-1,143000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,152,538
Cost of Revenue-603,017
Gross Profit1,549,5211,549,521
 
Operating Income (+$)
Gross Profit1,549,521
Operating Expense-1,651,037
Operating Income501,501-101,516
 
Operating Expense (+$)
Research Development194,992
Selling General Administrative690,741
Selling And Marketing Expenses-
Operating Expense1,651,037885,732
 
Net Interest Income (+$)
Interest Income29,224
Interest Expense-33,436
Other Finance Cost-22,712
Net Interest Income18,500
 
Pretax Income (+$)
Operating Income501,501
Net Interest Income18,500
Other Non-Operating Income Expenses-
Income Before Tax (EBT)527,781501,501
EBIT - interestExpense = -33,436
402,038
435,474
Interest Expense33,436
Earnings Before Interest and Taxes (EBIT)-561,218
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax527,781
Tax Provision-125,743
Net Income From Continuing Ops402,038402,038
Net Income402,038
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--18,500
 

Technical Analysis of Sanjin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sanjin. The general trend of Sanjin is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sanjin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guilin Sanjin Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 18.05 < 18.14 < 19.86.

The bearish price targets are: 14.83 > 14.65 > 13.92.

Tweet this
Guilin Sanjin Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guilin Sanjin Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guilin Sanjin Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guilin Sanjin Pharmaceutical Co Ltd. The current macd is 0.27106545.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sanjin price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sanjin. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sanjin price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Guilin Sanjin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartGuilin Sanjin Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guilin Sanjin Pharmaceutical Co Ltd. The current adx is 25.48.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sanjin shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Guilin Sanjin Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guilin Sanjin Pharmaceutical Co Ltd. The current sar is 14.44.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Guilin Sanjin Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guilin Sanjin Pharmaceutical Co Ltd. The current rsi is 62.83. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Guilin Sanjin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartGuilin Sanjin Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guilin Sanjin Pharmaceutical Co Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sanjin price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Guilin Sanjin Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartGuilin Sanjin Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guilin Sanjin Pharmaceutical Co Ltd. The current cci is 164.08.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Guilin Sanjin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartGuilin Sanjin Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guilin Sanjin Pharmaceutical Co Ltd. The current cmo is 28.26.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Guilin Sanjin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartGuilin Sanjin Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guilin Sanjin Pharmaceutical Co Ltd. The current willr is -28.74251497.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Sanjin is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Guilin Sanjin Pharmaceutical Co Ltd Daily Williams %R ChartGuilin Sanjin Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guilin Sanjin Pharmaceutical Co Ltd.

Guilin Sanjin Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guilin Sanjin Pharmaceutical Co Ltd. The current atr is 0.40376534.

Guilin Sanjin Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartGuilin Sanjin Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guilin Sanjin Pharmaceutical Co Ltd. The current obv is 185,626,339.

Guilin Sanjin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartGuilin Sanjin Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guilin Sanjin Pharmaceutical Co Ltd. The current mfi is 61.43.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Guilin Sanjin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartGuilin Sanjin Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guilin Sanjin Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Guilin Sanjin Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guilin Sanjin Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.829
Ma 20Greater thanMa 5014.508
Ma 50Greater thanMa 10014.085
Ma 100Greater thanMa 20014.354
OpenGreater thanClose15.050
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sanjin with someone you think should read this too:
  • Are you bullish or bearish on Sanjin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sanjin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guilin Sanjin Pharmaceutical Co Ltd

I send you an email if I find something interesting about Guilin Sanjin Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Guilin Sanjin Pharmaceutical Co Ltd.

Receive notifications about Guilin Sanjin Pharmaceutical Co Ltd in your mailbox!